Texas Health Harris Methodist Hospital Fort Worth at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

Texas Health Harris Methodist Hospital Fort Worth brings 2 presentations to IDWeek 2026 in Washington. Its program spans antibiotic safety and diagnostic stewardship. It compares cefepime neurotoxicity when the drug is given by intravenous push or piggyback and tests how accurate the MRSA nasal PCR is in skin and soft tissue infections.

OrganizationIDWeek 2026 Attendance
Poster
Fri Oct 23
12:15pm–1:30pm
Comparison of Cefepime-Induced Neurotoxicity Rates Using Intravenous Push vs Intravenous Piggyback Administration Strategies
Poster Hall B-C · Poster P-1806
S2. Antimicrobial Stewardship outcomes assessment (clinical and economic)
Poster
Fri Oct 23
12:15pm–1:30pm
Diagnostic Accuracy of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal PCR Test in Skin and Soft Tissue Infections where Empiric MRSA Therapy is Routinely Recommended
Poster Hall B-C · Poster P-1901
S3. Antibiotic Stewardship: Diagnostics/Diagnostic Stewardship

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Texas Health Harris Methodist Hospital Fort Worth

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction